Join us for an exciting event as the Silverman statue becomes the center of attention! Witness the launch of 100% ...

Cardiovascular diseases, represented by myocardial infarction and cerebral infarction, are primarily caused by narrowed arteries and blood clots (thrombi) that block blood flow. Aspirin is known as a ...

Dr Aggarwal says that high blood pressure, elevated cholesterol and smoking can increase the risk of suffering from a stroke.

Tom Nolan reviews this week’s research Aspirin is the first choice antiplatelet therapy for people with stable coronary heart disease. However, an individual patient data meta-analysis of seven ...

Importance During neurointerventional treatment of intracranial aneurysms, poor responses to antiplatelet drugs increase the risk of cerebral ischemic events. Objective To determine whether platelet ...

Adding ticagrelor to aspirin appears to carry benefits, at least early on, but also ups bleeding—de-escalation could be a fix ...

Although dual antiplatelet therapy (DAPT) has been shown to reduce graft failure after coronary artery bypass grafting (CABG), it may also increase the risk of clinically relevant bleeding.  The ...

TxB2 is a biomarker indicating aspirin's effect on platelet aggregation, the clumping of platelets that leads to dangerous blood clots This rapid inhibition is critical during suspected heart attacks, ...

MADRID, Spain—Aspirin is harmful for patients with a chronic coronary syndrome, a high atherothrombotic risk, and an indication for oral anticoagulation (OAC) who are more than 6 months out from PCI, ...

Background CYP2C19 genotyping has been widely studied to guide antiplatelet therapy in cardiovascular disease; however, its role in neurointerventional procedures, particularly for unruptured ...

Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease – despite stricter guidelines that no longer always call for it, a study finds. Almost one-quarter ...